Graft failure. (A) Cumulative incidence of GF for the whole cohort. (B) Cumulative incidence of GF for patients affected by diseases at high risk (ie, children affected by HLH, thalassemia, SAA, or osteopetrosis; red line) or at standard risk (blue line) for the complication.